Health Catalyst Inc.

AI Score

0

Unlock

5.63
-0.05 (-0.88%)
At close: Jan 22, 2025, 3:54 PM

Health Catalyst Statistics

Share Statistics

Health Catalyst has 60.85M shares outstanding. The number of shares has increased by 3.9% in one year.

Shares Outstanding 60.85M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.62%
Owned by Institutions (%) n/a
Shares Floating 58.53M
Failed to Deliver (FTD) Shares 120
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 2.56M, so 4.2% of the outstanding shares have been sold short.

Short Interest 2.56M
Short % of Shares Out 4.2%
Short % of Float 4.37%
Short Ratio (days to cover) 4.63

Valuation Ratios

The PE ratio is -4.42 and the forward PE ratio is 19.36.

PE Ratio -4.42
Forward PE 19.36
PS Ratio 1.77
Forward PS 0.9
PB Ratio 1.42
P/FCF Ratio -11.02
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Health Catalyst Inc. has an Enterprise Value (EV) of 665.23M.

EV / Earnings -5.63
EV / Sales 2.25
EV / EBITDA -9.74
EV / EBIT -5.24
EV / FCF -14.04

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.68.

Current Ratio 4.42
Quick Ratio 4.42
Debt / Equity 0.68
Total Debt / Capitalization 40.43
Cash Flow / Debt -0.13
Interest Coverage -17.41

Financial Efficiency

Return on equity (ROE) is -0.32% and return on capital (ROIC) is -20.66%.

Return on Equity (ROE) -0.32%
Return on Assets (ROA) -0.17%
Return on Capital (ROIC) -20.66%
Revenue Per Employee 227.64K
Profits Per Employee -90.88K
Employee Count 1.30K
Asset Turnover 0.42
Inventory Turnover 0

Taxes

Income Tax 356.00K
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -38.86% in the last 52 weeks. The beta is 1.32, so Health Catalyst 's price volatility has been higher than the market average.

Beta 1.32
52-Week Price Change -38.86%
50-Day Moving Average 7.58
200-Day Moving Average 7.17
Relative Strength Index (RSI) 29.94
Average Volume (20 Days) 612.87K

Income Statement

In the last 12 months, Health Catalyst had revenue of 295.94M and earned -118.15M in profits. Earnings per share was -2.09.

Revenue 295.94M
Gross Profit 131.83M
Operating Income -126.90M
Net Income -118.15M
EBITDA -68.28M
EBIT -126.90M
Earnings Per Share (EPS) -2.09
Full Income Statement

Balance Sheet

The company has 106.28M in cash and 249.07M in debt, giving a net cash position of -142.79M.

Cash & Cash Equivalents 106.28M
Total Debt 249.07M
Net Cash -142.79M
Retained Earnings -1.12B
Total Assets 813.05M
Working Capital 133.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.08M and capital expenditures -14.31M, giving a free cash flow of -47.39M.

Operating Cash Flow -33.08M
Capital Expenditures -14.31M
Free Cash Flow -47.39M
FCF Per Share -0.84
Full Cash Flow Statement

Margins

Gross margin is 44.55%, with operating and profit margins of -42.88% and -39.92%.

Gross Margin 44.55%
Operating Margin -42.88%
Pretax Margin -39.8%
Profit Margin -39.92%
EBITDA Margin -23.07%
EBIT Margin -42.88%
FCF Margin -16.01%

Dividends & Yields

HCAT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -36.8%
FCF Yield -13.7%
Dividend Details

Analyst Forecast

The average price target for HCAT is $10, which is 76.1% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 76.1%
Analyst Consensus Buy
Analyst Count 11
Stock Forecasts

Scores

Altman Z-Score -1.31
Piotroski F-Score 4